Intrinsic Value of S&P & Nasdaq Contact Us

Alcon Inc. ALC NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • CH • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
$153.96
+92.6%
Analyst Price Target
$91.02
+13.9%

Alcon Inc. (ALC) reported total assets of $31.56B and total liabilities of $9.52B for fiscal year 2025, resulting in total equity of $22.04B.

The company held $1.61B in cash and short-term investments. Total debt stood at $5.25B, with net debt of $3.72B. The Debt-to-Equity (D/E) ratio was 0.24 (conservative).

Current ratio is 2.12, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.24, current ratio of 2.12 — balance sheet is strong
  • MOAT (80/100) — Total assets $31.56B and equity $22.04B support the company's competitive scale
  • VALUE (44/100) — Debt-to-Equity 0.24 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
72/100
SG Score
View full scorecard →
~
VALUE
44/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
80/100
→ Income
GROWTH
83/100
→ Income
~
INCOME
45/100
→ Income
Alcon Inc. Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $31.56B$30.35B$29.61B$29.21B
Total Liabilities $9.52B$8.79B$8.99B$9.53B
Total Debt $5.25B$5.14B$5.14B$5.07B
Cash & Investments $1.61B$1.83B$1.1B$980M
Total Stockholders Equity $22.03B$21.55B$20.62B$19.68B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message